FDA Investigator Robert Darius
Robert Darius has conducted inspections on 2 sites in 2 countries as of 16 Oct 2000. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
16 Oct 2000
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Puerto Rico,
United States of America
FDA Investigators that have inspected at least one site in common with Robert Darius:
Adaliz Santaliz Cruz,
Alan A Rivera,
Amalia C Himaya,
Andrea George, PhD,
Anita Narula, PhD,
Arlene M Badillo,
Ashley N Queen, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brien C Fox,
Calvin B Koerner,
Carla J Lundi,
Caryn M Mcnab,
Cheron M Portee,
Christina C Santos,
Christina V Santos,
Christopher Downey, PhD,
Colleen Thomas, PhD,
Daniel W Cline,
Davinna Ligons, PhD,
Dennis Cantellops Paite,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donald C Obenhuber, PhD,
Donna Ltartaglino Besone,
Dov H Pluznik, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Eliezar Ramos,
Erika V Butler,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
Ivis L Negron,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer Lalama,
Jennifer M Gogley,
Jerri Baker,
Joel Welch, PhD,
John R Myung,
Jorge L Lajara,
Jose A Lopez,
Jose Acruz Gonzalez,
José E Meléndez,
Jose R Lopez,
Jose Velez,
Junho Pak,
Ka L Wong,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Laura Fontan, MS,
Leonard H Lavi,
Libia M Lugo,
LT Rafael Gonzalez,
Marcia B Williams,
Marcus F Yambot,
Maria Gutierrez Lugo, PhD,
Marian E Ramirez,
Maxwell Van Tassell, PhD,
Maxyne T Lam,
Michael A Charles,
Michael Shanks, MS,
Michelle A Marsh,
Michelle Yclark Stuart,
Mihaly S Ligmond,
Milva E Melendez Perales,
Mohsen Rajabi Abhari, FDA,
Myriam M Sosa,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Nikolay Spiridonov,
Noreen Muñiz,
Nydia E Colon,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paul Z Balcer,
Paula A Trost,
Peter S Diak,
Ramesh Potla, PhD,
Ramon A Hernandez,
Rebecca E Dombrowski,
Rebecca Parrilla,
Rebecca Rodriguez,
Richmond K Yip,
Riley C Myers, PhD,
Robert D Tollefsen,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sarah Arden,
Scott R Nichols, PhD,
Sidney B Priesmeyer,
Sonia R Peterson,
Stanley Au,
Steven C Madzo,
Steven Fong, MS, PhD,
Taichun Qin, PhD,
Tamika White,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thomas J Arista,
Timothy Wadkin, PhD,
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Wendy G Tan, PhD,
Yumi J Hiramine,
Yvonne C Wilkes,
Zachary L Stamm,
Zhong Li, PhD
Robert Darius's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| October, 2000 | FDA 483 | Amgen, Inc - Form 483, 2000-10-20 |
| October, 2000 | EIR | Amgen Manufacturing Limited LLC - EIR, 2000-10-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more